Jane Street Group, LLC Obs Eva Sa Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.56 - $3.35 $27,924 - $36,541	-10,908 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$2.01 - $5.05 $9,929 - $24,947	-4,940 Reduced 31.17%	10,908 $35,000
Q4 2020 Feb 17, 2021	BUY	$1.89 - $2.55 $9,245 - $12,474	4,892 Added 44.65%	15,848 $33,000
Q3 2020 Nov 17, 2020	BUY	$2.46 - $6.15 $26,951 - $67,379	10,956 New	10,956 $27,000
Q1 2019 May 16, 2019	SELL	$11.82 - $14.48 $203,788 - $249,649	-17,241 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$10.8 - $17.94 $186,202 - $309,303	17,241 New	17,241 $218,000
Q3 2018 Nov 14, 2018	SELL	$10.92 - $18.18 $251,968 - $419,485	-23,074 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$10.0 - $17.87 $230,740 - $412,332	23,074 New	23,074 $349,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.